Sign in

CIK 0001664710 · Non-accelerated filer<br>Smaller reporting company

Keros Therapeutics, Inc.

Sign in to watch
Ticker
KROS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
811173868
Phone
617-314-6297
Business address
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 8-K Event Regulation FD disclosure
  6. 8-K Event Shareholder vote results
  7. 8-K Event Executive or director change
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. S-3ASR Offering Registration Statement
  11. ARS Other Annual Report to Security Holders
  12. DEFA14A Proxy Proxy Materials
  13. DEF 14A Proxy Proxy Statement
  14. 8-K Event Other events
  15. 8-K Event Regulation FD disclosure
  16. 8-K Event Regulation FD disclosure
  17. 8-K Event Executive or director change
  18. S-8 Other Securities Offered to Employees in Benefit Plans
  19. 10-K Report Annual Report
  20. 8-K Event Results of operations

Page 11 of 27 · 537 filings